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Introduction.Asymptomaticbacteriuria(ASB),occurringin2–11%ofpregnancies,isamajorpredispositiontothedevelopmentof
pyelonephritis, which is associated with obstetrical complications, such as preterm labor and low birth weight infants. The aim of
this study was to determine the prevalence of ASB, the antibacterial susceptibilities of the isolated microorganisms and the associ-
ated riskfactors in an outpatient clinical setting in Zekai Tahir Burak Women’s Health Education and Research Hospital in Ankara,
Turkey. Material and Methods. Between December 2009 and May 2010, pregnant women admitted to the antenatal outpatient
clinic were included in this study. The results of a complete urine analysis, midstream urine culture and antibacterial susceptibility
were evaluated. Results. Of the 2011 pregnant women included, 171 had ASB (8.5%). E. coli was the most frequently isolated
microorganism (76.6%), followed by Klebsiella pneumonia (14.6%). Both microorganisms were highly sensitive to fosfomycin,
sensivity being 99.2% for E. coli and 88% for Klebsiella pneumonia. Conclusions. In this certain geographical region, we found E.
coli as the most common causative agent of ASB in the obstetric population and it is very sensitive to fosfomycin. We recommend
fosfomycin for ASB in pregnant women due to its high sensitivity, ease of administration and safety for use in pregnancy.
1.Introduction
Urinary tract infections (UTI) are the most common bac-
terial infections of pregnancy [1]. Asymptomatic bacteriuria
(ASB), occurring in 2–11% of pregnancies, is a major pre-
disposition to the development of pyelonephritis, which is
associated with obstetrical complications, such as preterm
labor and low birth weight infants. Bacteriuria is deﬁned as
the presence of >105 colonies of a single pathogen per mil-
liliter of urine. It may be either an asymptomatic bacteriuria
(ASB of pregnancy) or symptomatic acute cystitis and acute
pyelonephritis [2].
When left untreated, ASB may lead to symptomatic
uriner tract infections (UTI) [3]. Untreated, ASB is found
to be associated with subsequent acute pyelonephritis in 20–
50% of cases [4].
The female urethra is relatively short and is anatomically
proximal to the vagina, which is colonized with organisms
fromthegastrointestinaltract.Normalphysiologicalchanges
inpregnancyplacewomenatriskforpyelonephritis. Thereis
also relative obstruction of the ureters because the enlarging
uterus physically blocks them, and the hormonal milieu of
pregnancy leads to relaxation of the smooth muscle of the
ureters and the bladder. Furthermore, the glycosuria and
aminoaciduria of pregnancy provide an excellent medium
for bacterial proliferation [5–7].
The relatively high prevalence of ASB during pregnancy,
the signiﬁcant consequences for women and pregnancy, and
the ability to avoid undesired outcomes with treatment
justify screening and treatment of ASB in pregnancy [8].
The frequency of isolated pathogens and antimicrobial
resistancepatternscanvaryindiﬀerentgeographicalregions;2 ISRN Obstetrics and Gynecology
therefore, the most common causative agents should be
investigated and communities should be aware of their local
antimicrobial resistances. The objective of this prospective
study was to identify the prevalence of ASB, the most com-
mon causative agents and the antibacterial susceptibilities
of the isolated microorganisms in a Research Hospital in
Ankara, Turkey.
2.MaterialsandMethod
Between December 2009 and May 2010, 2011 of 2132
pregnant women applying for their ﬁrst antenatal visit to the
Zekai Tahir Burak Women’s Health Education and Research
Hospital antenatal outpatient clinic were recruited into the
study. The remaining 121 women refused to take part in this
study, and informed consent for the participating patients
was taken. Patients with fever, urinary symptoms (such as
dysuria, hesitancy, urgency, frequent voiding, incontinence
and incomplete voiding), current antibiotic therapy, and a
history of urolithiasis and diabetes were excluded. Urine
cultures of these symptomatic patients were collected and
antimicrobial therapy was given accordingly.
Along with the routine antenatal laboratory tests, pati-
ents were instructed to collect mid-stream urine samples.
Collected samples were immediately inoculated on 5% sheep
blood agar and eosin-methylene blue agar plates with a
0.01-mL loop. After 24–48 hours of aerobic inoculation
at 37◦C, the plates were interpreted. Colony counts of a
singlemicroorganismof>105 colonyformingunits(cfu)/mL
were interpreted as bacteriuria. The presence of multiple
organisms or of skin ﬂora was considered to result from
contamination.
Antimicrobial susceptibility testing by disc diﬀusion
was employed according to the Clinical and Laboratory
Standards Institute Guidelines. Identiﬁcation and antimicro-
bial susceptibility testing of microorganisms was performed
according to the Clinical and Laboratory Standards Institute
Guidelines with conventional microbiological methods and
conﬁrmed by The BD Phoenix Automated Microbiology
System (BD Diagnostics, Sparks, MD). The Phoenix is
designed for the rapid identiﬁcation (ID) and antimicrobial
susceptibility testing (AST) of clinically signiﬁcant human
bacterial pathogens. The Phoenix identiﬁcation method uses
modiﬁed conventional, ﬂuorogenic, and chromogenic sub-
strates. Research-use-only combination panels (UMIC/ID)
for both the identiﬁcation and susceptibility testing were
used for this comparison. Software versions V3.34A and
V3.54A were used for this study. The ID side contains 45
wells with dried biochemical substrates and 2 ﬂuorescent
control wells. The ID broth was inoculated with bacterial
colonies from a pure culture that was adjusted to a 0.5
McFarland standard by using a CrystalSpec nephelometer
(BD Diagnostics) according to the manufacturer’s recom-
mendations. A 25-µL aliquot of this suspension was removed
for AST, and the remaining suspension was then poured
into the ID side of the Phoenix panel. The specimen was
logged and loaded into the instrument within the speciﬁed
timeline of 30min. Quality control was performed according
to the manufacturer’s recommendations. The AST side of
Table 1: Demographic characteristics of the pregnant women
screened for asymptomatic bacteriuria.
Characteristics Non-
Bacteriuria Bacteriuria P Value
Age (years)
Mean (SD) 24.6 (5.1) 23.9 (5.0) >.05
Range 17–43 17–44
Pregnancy
Mean (SD) 1.96 (1.0) 2.01 (1.1) >.05
Range 0–6 0–7
Parity
Mean (SD) 0.86 (0.92) 0.91 (0.98) >.05
Range 0–5 0–6
Hemoglobin (g/dL)
Mean (SD) 12.8 (6.8) 11.1 (5.3) .01
Range 8.3–14.9 7.6–13.7
SD = standard deviation.
Table 2: Bacteriologic isolates from pregnant women with asymp-
tomatic bacteriuria.
Microorganism (s) N (%)
E. coli 131 (76.6)
Klebsiella pneumoniae 25 (14.6)
Enterococcus faecalis 7 (4)
Klebsiella oxytoca 2 (1.2)
Proteus spp. 2 (1.2)
Enterobacter sakazakii 1 (0.6)
Enterococcus spp. 1 (0.6)
Staphylococcus aureus 1 (0.6)
Staphylococcus saprophyticus 1 (0.6)
Total 171 (100)
the combination panel contains up to 84 wells with dried
antimicrobial panels and growth control well. The assay is a
broth-basedmicrodilutiontest.Thesystemusesaredoxindi-
cator for the detection of organism growth in the presence
of an antimicrobial agent. The previously described 25µLo f
the standardized ID broth suspension was transferred to the
AST broth, yielding a ﬁnal concentration of approximately 5
× 105 CFU/mL. Quality control was performed according to
the manufacturer’s recommendations.
The diﬀerences in the demographic features between the
two groups were analyzed by the SPSS v14.0 Student’s t-test.
3. Results
Demographic features of the women screened for ASB are
displayed in Table 1. Age, gravid, and parity are similar
between the two groups (P>. 05). Hemoglobin levels,
however,displayasigniﬁcantdiﬀerencebetweentheASBand
nonbacteriuria groups (P = .01).
Of the 2011 pregnant women included in the study, 171
(8.5%)hadASB.E.coli,detectedin131(76.6%)patients,wasISRN Obstetrics and Gynecology 3
Table 3: Gram negative microorganisms.
Amo/clav Am Cf Cef Ceft Cefu Fos Fm Sxt
Microorganism (s) Antibiotics sensitivity (%)
E. coli 89 75 115 120 118 113 130 125 108
(68) (57.2) (87) (91.6) (90) (86) (99.2) (95.4) (82)
Klebsiella
pneumoniae
2 1 1 2 32 52 52 12 2 9 2 5
(84) (4) (92) (100) (100) (84) (88) (36) (100)
Klebsiella oxytoca 0 00000212
(100) (50) (100)
Proteus spp. 2 12222220




(100) (100) (100) (100) (100) (100)
Amo/clav=amoxicillin/clavulanic acid, Am=ampicillin, Cf=Cefazoline, Cef=Cefepime, Ceft=Ceftriaxone, Cefu=Cefuroxime, Fos=Fosfomycin,
Fm=Nitrofurantoin, Sxt=co-trimoxazole.
Table 4: Gram positive microorganisms.
Am Fos penG Sxt Clin Eryt Fm
Microorganism (s) Antibiotics sensitivity (%)
Enterococcus
faecalis
7 7 6 N DN DN DN D
(100) (100) (85.7)








0N D0 1N D N D N D
(100)
Am=ampicillin, Fos=Fosfomycin, PenG=Penicillin G, Sxt=co-trimoxazole, Clin=Clindamycin, Eryt=Erythromycin, Fm=Nitrofurantoin, ND=not
done.
the most frequently isolated organism, followed by Klebsiella
pneumonia, which was found in 25 (14.6%) of the cases.
Table 2 shows the isolated microorganisms.
E. coli, the most common isolate, was found to be only
57.2% and 68% sensitive to ampicillin and amoxicillin +
clavulanate, respectively. Its sensitivity fosfomycin was very
high, 99.2%. Sensitivities to ceftriaxone and ciproﬂoxacin
were both 90%, and sensitivity to amikacin was 99%.
A 100% sensitivity was found for the broad spectrum
penicillins imipenem and meropenem. An 86% sensitivity
was documented for cefuroxime, a commonly prescribed
oral agent for UTIs in pregnancy.
Klebsiella pneumonia, the second most frequent organ-
ism grown on the cultures, was only 4% sensitive to ampi-
cillin, while its sensitivity to amoxicillin/clavulanic acid was
84%. We found a 88% sensitivity to fosfomycin. Sensitivity
to cefuroxime was 84%, and a 100% sensitivity was found
for cefepime, ceftriaxone, imipenem, and meropenem.
Antibiotic sensitivities of the isolated gram (−)a n dgra m
(+) microorganism are shown separately in Tables 3 and 4.
4. Discussion
Pregnant women with ASB are more likely to deliver
premature or low birth weight infants and have a 20–30-
fold increased risk of developing pyelonephritis compared to
women without bacteriuria [9].
In this study, 171 of 2011 (8.5%) pregnant women had
ASB, which is comparable with the results of studies by Uncu
et al. [10] in 2002 and Hazhir [11] in 2007. E. coli was
the most common isolate (76.6%), which is consistent with
previous studies [12–14].
E. coli, the most frequent isolate, was 99.2% sensitive
to fosfomycin. Fosfomycin is an oral agent administered in
a single dose with relatively limited side eﬀects. Klebsiella
pneumonia, the second most common microorganism iso-
lated in this study is, also 88% sensitive to fosfomycin.
Ampicillin and amoxicillin/clavulanate are two fre-
quently prescribed oral antimicrobial agents for UTI in
pregnant women. Our culture results yielded 57.2% and
68% sensitivities to these agents, respectively. Cefuroxime is4 ISRN Obstetrics and Gynecology
another drug commonly prescribed for treating ASB, and
sensitivity to this drug was 86%, which is comparable to
that of cefazolin (87%), cefepime (91.6%), and ceftriaxone
(90%). Sensitivities to imipenem and meropenem were both
100% (Table 3).
In some studies, gram-positive microorganisms are
found to be important causative agents of ASB. Enayat et
al. reported that up to 16.8% of causative organisms are
coagulase-negative staphylococci [13]. In our study, only
5.8% of the urinary isolates were gram-positive organisms,
the most frequent one being Enterococcus faecalis (4%).
Contributing risk factors for developing bacteriuria
during pregnancy are age, parity, sexual intercourse, diabetes
mellitus, sickle cell disease, trait, anatomical abnormalities
of the urinary tract, previous history of UTI, and socioe-
conomic status [15–18] .I nt h i ss t u d y ,f o u rv a r i a b l e s ,a g e ,
parity, and hemoglobin levels, were evaluated. Among these
variables, hemoglobin levels were associated with ASB (P =
.01). Because an association between bacteriuria and anemia
hasnotbeenconﬁrmed,weconcludedthatthisresultmaybe
attributed to the confounding eﬀects of low socioeconomic
status.
Two of the most important points to consider in the
choice of antimicrobial agents for use in a population of
pregnant women within a certain geographical region are
the frequently isolated urinary pathogens and the patterns
of antimicrobial resistance.
5. Conclusion
Every symptomatic or asymptomatic woman should have
a clean-catch urine culture, and detected cases should be
treated according to the antimicrobial susceptibility tests. A
clean-catch culture is the most sensitive test for the detection
o fA S B ,b u ti ti se x p e n s i v ea n dr e q u i r e st r a i n e dl a b o r a t o r y
staﬀ. When these facilities are not available, knowledge of
the most frequent isolates and local antimicrobial resistance
patterns will aid physicians in the successful empirical
treatment of the infection.
In this certain geographical region, we found E. coli as
the most common causative agent of ASB in the obstetric
population and it is very sensitive to fosfomycin. We
recommend fosfomycin for ASB in pregnant women due to
its high sensitivity, ease of administration, and safety for use
in pregnancy.
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